Nastent Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.36M

  • Investors
  • 1

Nastent General Information

Description

Developer of medical devices designed to improve sleep quality. The company's device helps the airway during sleep by inserting a soft tube into the nose, applying the method of securing the airway during emergency lifesaving, enabling individuals and patients to make the right choice for snoring and sleep apnea without preventing airway obstruction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4-14-7 Nishi-Shinjuku
  • Shinjuku-ku
  • Tokyo
  • Japan
+81
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 4-14-7 Nishi-Shinjuku
  • Shinjuku-ku
  • Tokyo
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nastent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 27-Feb-2020 $1.36M Completed Generating Revenue
1. Angel (individual) 30-Sep-2019 Completed Startup
To view Nastent’s complete valuation and funding history, request access »

Nastent Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A preferred
Ordinary
To view Nastent’s complete cap table history, request access »

Nastent Patents

Nastent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4494683-A1 Nasal cavity insertion device Pending 18-Mar-2022
EP-4494683-A4 Nasal cavity insertion device Pending 18-Mar-2022
US-12508149-B2 Nasal cavity insertion device Active 18-Mar-2022
US-20250195254-A1 Nasal cavity insertion device Active 18-Mar-2022
WO-2023175887-A1 Nasal cavity insertion device Inactive 18-Mar-2022 A61F5/08
To view Nastent’s complete patent history, request access »

Nastent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nastent Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Create Medic Corporation Minority
To view Nastent’s complete investors history, request access »

Nastent FAQs

  • When was Nastent founded?

    Nastent was founded in 2018.

  • Where is Nastent headquartered?

    Nastent is headquartered in Tokyo, Japan.

  • What is the size of Nastent?

    Nastent has 3 total employees.

  • What industry is Nastent in?

    Nastent’s primary industry is Therapeutic Devices.

  • Is Nastent a private or public company?

    Nastent is a Private company.

  • What is the current valuation of Nastent?

    The current valuation of Nastent is .

  • What is Nastent’s current revenue?

    The current revenue for Nastent is .

  • How much funding has Nastent raised over time?

    Nastent has raised $2.57M.

  • Who are Nastent’s investors?

    Create Medic has invested in Nastent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process